NARI - Inari Medical (NARI) Faces DOJ Probe and Investor Backlash Amid Kickback Allegations– Hagens Berman | Benzinga
SAN FRANCISCO, July 06, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now.
Class Period: Feb. 24, 2022 – Feb. 28, 2024
Lead Plaintiff Deadline: July 12, 2024
Visit: www.hbsslaw.com/investor-fraud/nari
Contact the Firm Now: NARI@hbsslaw.com
844-916-0895
Inari Medical Class Action:
Inari Medical, Inc. (NASDAQ:NARI), a leading medical device manufacturer, finds itself embroiled in a complex legal battle as the U.S. Department of Justice (DOJ) intensifies its scrutiny. The investigation centers on allegations of illicit kickbacks to healthcare professionals, a revelation that has sent shockwaves through the company and its investor community.
The DOJ's Inquisition
In late February, Inari publicly disclosed that it had received a Civil Investigative Demand (CID) from the DOJ's Civil Division. The CID pertains to ...
NARI) Faces DOJ Probe and Investor Backlash Amid Kickback Allegations– Hagens Berman>Full story available on Benzinga.com